CD133-responsive conditionally replicating adenovirus targeting cancer stem cells
| Project/Area Number |
23701062
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Tumor biology
|
|---|
| Research Institution | Kagoshima University |
|---|
Principal Investigator |
WANG Yuqing 鹿児島大学, 医歯(薬)学総合研究科, 特任研究員 (20505143)
|
|---|
| Project Period (FY) |
2011-04-28 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2013: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 腫瘍生物学 / 癌幹細胞 / 遺伝子治療 / アデノウイルス / 国際研究者交流 / アデノウイルスベクター |
|---|
| Outline of Final Research Achievements |
Cancer stem cells has been note as an important therapeutic target in cancer, and gene therapy such as by virotherapy focused on cancer stem cell maybe provides a novel therapeutic approach to anticancer. CD133 is known as a cancer stem marker expressed in nervous system tumors, colon cancer and prostate cancer, etc. A novel conditionally replicating adenovirus vector CD133pr.m-CRA was constructed and showed cancer stem cell-specific therapy effect in vitro and in vivo tumor model without toxicity to normal cells. Our date indicate that CD133.m-CRAs is a useful strategy for treating cancer stem cells.
|
Report
(5 results)
Research Products
(9 results)
